FAST Graphs Analyze out Loud Video Bristol-Myers Squibb (BMY) | FAST Graphs

Many of you, if you follow Bristol-Myers Squibb (BMY), all know that they recently merged with Celgene and they’ve now become a much bigger company.  What’s been happening in big pharma, even the big names like Merck and Pfizer, these were very strong growth stocks years ago, but in more recent times their growth has slowed quite a bit.

Growth is expected to be real strong going out for the next couple of years.  So all in all, I really like Bristol-Myers (BMY).  I think it’s a great selection for anyone who’s looking for above-average dividend income, but also some capital gain potential, especially out over the next three to five years.

Subscribe to our YouTube Channel

Click here for The Dividend Kings two-week free trial:

Try FAST Graphs for FREE Today!

#dividends #investing #stocks

[DavenThea]

Chuck, Thank you for making your analysis available to the public; much appreciated.

[michaelprasse]

You were right on PFE and you’ll be right on BMY. For what it’s worth bmy is a top 10 hedge fund stock as well. An update on enterprise product partners would be much appreciated

[larrymanetti]

forgot to thank you for the video. BMY has a very good ceo too which helps a lot. With abbv probably the best pharma out there.

[puppypuppy]

THANK YOU for this analysis! Am a very long term BMY shareholder and really appreciate your insights.

[leihoa]

Can you do some longer video about pharma industry as a whole? There are amazing stocks there, say - EXEL, or BIIB. First has zero debt and astronomical growth projections, second one also low debt and great balance sheet. Not dividend stocks, but there is value there, I think...

[doubleinfinification]

this might be a dumb question, but a stock like ABBV is trading at a PE of about 20 right now, and on fast graphs it's showing it well below the normal PE line and even well below the 15 line. can anyone explain this to me?

[ynsam]

Chuck, When do you do QnA sessions? Would love to join one.

[Soosakasees]

Can you do Novartis next? Thanks for the work, chuck.

[CTBoi]

Chuck, would love to see an analysis of CTAS - it has been screening moderately well in my dividend screen on BBG. thanks for all you do!

[TheMrBougna]

You are using non-GAAP data, how can this be reliable?